#synbio podcast by iGEM
Kathryn Hamilton is the Managing editor and senior staff writer at Bioeconomy.XYZ. As well as Senior Consultant, (Biomedical Positioning) at Booz Allen Hamilton. She believes that Biotechnology is humanity’s highest art form. In this episode, Shrestha sits down with Kathryn to discuss:
Todd Is a senior research scholar and executive committee member at NC states genetic engineering and society center. His work explores the scientific and technological frontier, stimulating discovery and bringing new tools to bear on public policy challenges that emerge as science advances.
Miroslav Gasparek is a PhD candidate in engineering science at Oxford University. He’s also a venture fellow at Civilisation ventures, and part of the steering committee at the European Union SynBio society.
Drew has served on the US National Science Advisory Board for Biosecurity and the Committee on Science, Technology, & Law; he currently serves on the World Health Organization’s Smallpox Advisory Committee. Esquire magazine recognized Drew as one of the 75 most influential people of the 21st century.
Is climate change opening the floodgates of the germ zoo? Are Silicon Valley investors understanding and accepting climate change? In this episode, Zeeshan chats with Arvind Gupta and Po Bronson about their book, Decoding The World, where they try and decode the real cause of the pandemic, climate change, iGEM and SynBio & Silicon Valley!
Deepmind’s work and success in protein structure prediction shows how exciting of a time it is to be part of biology and science in general. AlphaFold 2 is revolutionary, and to help me understand the science behind it, I'm joined by Charlie Harris. Charlie is currently finishing off his masters degree in Bioinformatics and Theoretical Systems Biology at Imperial College London, where he is working with Prof Michael Bronstein looking into generative models for structure based drug design. Charlie is also the chair and founder of the Imperial College Computational Biology Society. He's also about to start a PhD at the University of Cambridge Centre for AI in Medicine.
Doug is an Associate Professor of Electrical and Computer Engineering at Boston University. His research focuses on the development of tools for the specification, design, assembly and test of synthetic biological systems. On this episode, we discuss the relationship between robots and synthetic biology. As well as if automation is going to end up making SynBio more centralised.
